692 reports of this reaction
2.4% of all LOPINAVIR AND RITONAVIR reports
#8 most reported adverse reaction
PAIN is the #8 most commonly reported adverse reaction for LOPINAVIR AND RITONAVIR, manufactured by AbbVie Inc.. There are 692 FDA adverse event reports linking LOPINAVIR AND RITONAVIR to PAIN. This represents approximately 2.4% of all 28,252 adverse event reports for this drug.
Patients taking LOPINAVIR AND RITONAVIR who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is a less commonly reported adverse event for LOPINAVIR AND RITONAVIR, but still significant enough to appear in the safety profile.
In addition to pain, the following adverse reactions have been reported for LOPINAVIR AND RITONAVIR:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 692 FDA reports for LOPINAVIR AND RITONAVIR. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 2.4% of all adverse event reports for LOPINAVIR AND RITONAVIR, making it a notable side effect.
If you experience pain while taking LOPINAVIR AND RITONAVIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.